STOK Competitors & Alternatives
Compare Stoke Therapeutics Inc with similar stocks in the same industry
Biotechnology
STOK
Main Stock$30.08
Tradestie Score
57
Market Cap
$1.29B
Revenue Growth
-1.0%
Analyst Upside
+49.9%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.99
|
$2.08B | - | 53 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.55
|
$2.02B | 51.1 | 56 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.67
|
$2.01B | - | 53 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$32.68
|
$1.97B | - | 54 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.16
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$137.68
|
$1.92B | - | 60 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.93
|
$1.90B | 348.8 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.32
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.05
|
$1.81B | - | 50 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.09
|
$1.78B | - | 47 | Compare |
More STOK Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry